Skip to main content

Advertisement

Table 1 Comparison of patients' characteristics differentiated to the type of schedule

From: A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas

  SEQ (sequential, n = 70) CON (concomitant, n = 52) p
Parameter number (%) number (%) 0.80
Age, years      
Mean (Range) 53 (37–77)   52.8 (39–66)   0.79
Performance status (WHO)      0.67
0,1 35 (50) 30 (58)  
2,3 27 (39) 19 (37)  
Unknown 8 (11) 2 (4)  
T-stage (UICC)      0.54
T2 4 (6) 3 (6)  
T3 18 (26) 9 (17)  
T4 48 (68) 40 (77)  
N-stage      0.13
N2c 23 (33) 15 (29)  
N3 8 (11) 7 (14)  
RTOG stage groupings      0.58
III (T3-4 N0, T1-2 N2) 5 (7) 1 (2)  
IV (T1-2 N3, T3 N1-2, T4 N1) 23 (33) 16 (31)  
V (T4 N2-3) 41 (59) 35 (67)  
UICC stage groupings      
IV (a + b) 69 (99) 52 (100)  
Tumor location      0.19
Oral cavity 7 (10) 10 (19)  
Oropharynx 38 (54) 30 (58)  
Hypopharynx, Larynx 25 (36) 12 (23)  
Mean tumor size (cm) 4.8   4.6   0.46